PODCAST ONE
Overview of CF and Recognizing Health Disparities in its Care

Advancing Cystic Fibrosis:
Addressing Disparities, Challenging Perceptions, and Innovating Patient-Centered Care

Faculty

Susanna A. McColley, MD


Professor of Pediatrics in Pulmonary and Sleep Medicine; Director, Interdisciplinary Research Partnerships, Stanley Manne Children’s Research Institute, Ann & Robert H. Lurie Children’s Hospital of Chicago
Chicago, IL

Alexandra Wilson, MS, RDN, CDE​

Manager, Cystic Fibrosis Clinical Research​National Jewish Health​Denver, CO

Program Overview

Cystic Fibrosis (CF) is a complex condition with significant health disparities impacting patient outcomes. Despite advances in CF care, barriers like limited access, and unintended bias persist. This CME program aims to equip healthcare professionals with the necessary knowledge and skills to address these challenges, ensuring high-quality care for all CF patients. 

The activities address telehealth strategies and best practices for transitioning patients from pediatric to adult care. Strategies for managing co-morbidities and the impact of evolving treatments on patient outcomes will be discussed. 

Target Audience

This educational program is directed toward cystic fibrosis specialists, pulmonologists, pediatricians, gastroenterologists, nurse practitioners, physician assistants, nurses, and other clinicians who provide care for patients with CF.

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • REPORT the latest advancements in CF treatment through the critical analysis of clinical trial data, ensuring HCPs stay abreast of evolving therapeutic options.

Accreditation

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Iridium CE. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must
  • Read the learning objectives and faculty disclosures Complete the pretest
  • View the broadcast
  • Complete the posttest with a score of 70% or higher


A statement of credit will be issued within four weeks of receipt of a completed activity evaluation form.

Fee Information and Refund/Cancellation Policy

There is no fee for this educational activity.

Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com

Disclosures

Disclosures of Relevant Financial Relationships


​Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

Susanna McColley, MD
​Consulting Fee (e.g., Advisory Board): Vertex Pharmaceuticals, Inc.​
Contracted Research (Principal Investigators must provide information, even if received by the institution): Vertex Pharmaceuticals, Inc.​
Honoraria: Vertex Pharmaceuticals, Inc.

Alexandra Wilson, MS, RDN, CDE​
Nothing to disclose
 
The following planners and managers involved in the development of this activity have no relevant financial relationships with ineligible companies to disclose.
 
Global
The planners and managers at Global Education Group have no relevant financial relationships to disclose.

Iridium
The planners and managers at Iridium have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and Iridium do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
This activity is jointly provided by Global Education Group and Iridium Continuing Education.

SUPPORTER ACKNOWLEDGEMENT

This educational activity is supported by independent educational grants from Vertex Pharmaceuticals Incorporated.

Activity Credit Amount: 0.25
Credit Type: ACCME
Release: October 15, 2024
Expiration: October 15, 2025

info@iridiumce.com